465 related articles for article (PubMed ID: 25421480)
1. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794
[TBL] [Abstract][Full Text] [Related]
3. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
5. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
[TBL] [Abstract][Full Text] [Related]
6. The G9a Histone Methyltransferase Inhibitor BIX-01294 Modulates Gene Expression during
Ngwa CJ; Kiesow MJ; Orchard LM; Farrukh A; Llinás M; Pradel G
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31615031
[TBL] [Abstract][Full Text] [Related]
7. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K
Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives.
Korotchenko V; Sathunuru R; Gerena L; Caridha D; Li Q; Kreishman-Deitrick M; Smith PL; Lin AJ
J Med Chem; 2015 Apr; 58(8):3411-31. PubMed ID: 25654185
[TBL] [Abstract][Full Text] [Related]
10. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
[TBL] [Abstract][Full Text] [Related]
11. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
12. Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity.
Ashton TD; Ngo A; Favuzza P; Bullen HE; Gancheva MR; Romeo O; Parkyn Schneider M; Nguyen N; Steel RWJ; Duffy S; Lowes KN; Sabroux HJ; Avery VM; Boddey JA; Wilson DW; Cowman AF; Gilson PR; Sleebs BE
Bioorg Chem; 2021 Dec; 117():105359. PubMed ID: 34689083
[TBL] [Abstract][Full Text] [Related]
13. A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
Le Manach C; Paquet T; Brunschwig C; Njoroge M; Han Z; Gonzàlez Cabrera D; Bashyam S; Dhinakaran R; Taylor D; Reader J; Botha M; Churchyard A; Lauterbach S; Coetzer TL; Birkholtz LM; Meister S; Winzeler EA; Waterson D; Witty MJ; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Street LJ; Chibale K
J Med Chem; 2015 Nov; 58(21):8713-22. PubMed ID: 26502160
[TBL] [Abstract][Full Text] [Related]
14. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
[TBL] [Abstract][Full Text] [Related]
15. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
[TBL] [Abstract][Full Text] [Related]
16. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities.
Witschel MC; Rottmann M; Schwab A; Leartsakulpanich U; Chitnumsub P; Seet M; Tonazzi S; Schwertz G; Stelzer F; Mietzner T; McNamara C; Thater F; Freymond C; Jaruwat A; Pinthong C; Riangrungroj P; Oufir M; Hamburger M; Mäser P; Sanz-Alonso LM; Charman S; Wittlin S; Yuthavong Y; Chaiyen P; Diederich F
J Med Chem; 2015 Apr; 58(7):3117-30. PubMed ID: 25785478
[TBL] [Abstract][Full Text] [Related]
18. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel quinazoline derivatives as potent antiplasmodial agents.
Bouchut A; Rotili D; Pierrot C; Valente S; Lafitte S; Schultz J; Hoglund U; Mazzone R; Lucidi A; Fabrizi G; Pechalrieu D; Arimondo PB; Skinner-Adams TS; Chua MJ; Andrews KT; Mai A; Khalife J
Eur J Med Chem; 2019 Jan; 161():277-291. PubMed ID: 30366254
[TBL] [Abstract][Full Text] [Related]
20. Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Freund YR; Berry P; Ciaravino V; Erve JCL; Rosenthal PJ; Campo B; Gamo FJ; Sanz LM; Cao J
J Med Chem; 2017 Jul; 60(13):5889-5908. PubMed ID: 28635296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
